Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma
The role of Mycoplasma pneumoniae (Mp) in the initiation and persistence of asthma remains elusive. Mp community-acquired respiratory distress syndrome toxin (CARDS Tx) is a unique virulence factor that induces an intense lymphocytic response and exacerbates asthma in animal models. We sought to det...
Saved in:
Published in | Chest Vol. 140; no. 2; p. 401 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.08.2011
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The role of Mycoplasma pneumoniae (Mp) in the initiation and persistence of asthma remains elusive. Mp community-acquired respiratory distress syndrome toxin (CARDS Tx) is a unique virulence factor that induces an intense lymphocytic response and exacerbates asthma in animal models. We sought to determine the incidence of Mp infection and the presence of CARDS Tx in subjects with refractory asthma (RA).
We conducted a prospective observational study in 64 subjects with RA. Respiratory secretions (sputum, nasal lavage, and throat swab) and blood were analyzed for the presence of CARDS Tx and P1 adhesin (P1) DNA by polymerase chain reaction (PCR), and CARDS Tx by antigen capture. Serum IgM and IgG antibodies to CARDS Tx were determined by enzyme-linked immunosorbent assay (ELISA).
Thirty-three of 64 subjects (52%) tested positive for Mp: 29 of 33 by CARDS Tx vs 10 of 33 by P1 assays. Ten subjects followed longitudinally for up to 633 days tested persistently positive for Mp. There were no significant differences in Mp-specific IgG responses between Mp-positive and Mp-negative groups. Eight of 10 subjects who tested persistently positive failed to mount a substantial IgG response to CARDS Tx, and up to 8 weeks of clarithromycin failed to eradicate Mp in five subjects.
Subjects with RA may be chronically infected with Mp. PCR for CARDS Tx appears to be the most sensitive method of identifying Mp infection. Despite the persistence of Mp in subjects with RA, some subjects failed to mount an IgG response, and macrolide therapy was insufficient to eradicate Mp. |
---|---|
AbstractList | The role of Mycoplasma pneumoniae (Mp) in the initiation and persistence of asthma remains elusive. Mp community-acquired respiratory distress syndrome toxin (CARDS Tx) is a unique virulence factor that induces an intense lymphocytic response and exacerbates asthma in animal models. We sought to determine the incidence of Mp infection and the presence of CARDS Tx in subjects with refractory asthma (RA).
We conducted a prospective observational study in 64 subjects with RA. Respiratory secretions (sputum, nasal lavage, and throat swab) and blood were analyzed for the presence of CARDS Tx and P1 adhesin (P1) DNA by polymerase chain reaction (PCR), and CARDS Tx by antigen capture. Serum IgM and IgG antibodies to CARDS Tx were determined by enzyme-linked immunosorbent assay (ELISA).
Thirty-three of 64 subjects (52%) tested positive for Mp: 29 of 33 by CARDS Tx vs 10 of 33 by P1 assays. Ten subjects followed longitudinally for up to 633 days tested persistently positive for Mp. There were no significant differences in Mp-specific IgG responses between Mp-positive and Mp-negative groups. Eight of 10 subjects who tested persistently positive failed to mount a substantial IgG response to CARDS Tx, and up to 8 weeks of clarithromycin failed to eradicate Mp in five subjects.
Subjects with RA may be chronically infected with Mp. PCR for CARDS Tx appears to be the most sensitive method of identifying Mp infection. Despite the persistence of Mp in subjects with RA, some subjects failed to mount an IgG response, and macrolide therapy was insufficient to eradicate Mp. |
Author | Diaz, Joseph Kannan, Thirumalai R Singh, Harjinder Coalson, Jacqueline J Baseman, Janet G Cagle, Marianna Baseman, Joel B Peters, Jay Brooks, Edward G |
Author_xml | – sequence: 1 givenname: Jay surname: Peters fullname: Peters, Jay email: peters@uthscsa.edu organization: Department of Medicine, University of Texas Health Science Center at San Antonio, TX. Electronic address: peters@uthscsa.edu – sequence: 2 givenname: Harjinder surname: Singh fullname: Singh, Harjinder organization: Department of Medicine, University of Texas Health Science Center at San Antonio, TX – sequence: 3 givenname: Edward G surname: Brooks fullname: Brooks, Edward G organization: Department of Pediatrics, University of Texas Health Science Center at San Antonio, TX – sequence: 4 givenname: Joseph surname: Diaz fullname: Diaz, Joseph organization: Asthma and Allergy Associates of South Texas, San Antonio, TX – sequence: 5 givenname: Thirumalai R surname: Kannan fullname: Kannan, Thirumalai R organization: Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, TX – sequence: 6 givenname: Jacqueline J surname: Coalson fullname: Coalson, Jacqueline J organization: Department of Pathology, University of Texas Health Science Center at San Antonio, TX – sequence: 7 givenname: Janet G surname: Baseman fullname: Baseman, Janet G organization: Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, TX – sequence: 8 givenname: Marianna surname: Cagle fullname: Cagle, Marianna organization: Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, TX – sequence: 9 givenname: Joel B surname: Baseman fullname: Baseman, Joel B organization: Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, TX; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21622549$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kElLBDEYRIMozqJHr5I_kDFLd2dylMENFD3oefgmixOZJG2SBttf77idigfFg6oZOowpWoTOGF0wIZcXemtLXTBGKOfsAE2ZEoyIthETNCvljVLKmOqO0YSzjvO2UVP0-WRz8aXaqC1ODusUwhB9HQno98Fna3C2pfcZasojNvvqngsuYzQ5BYtr-vCR9DmZQfv4ih9GnfodlAC4j3YIKXqw2Me9xmXQPxYodRvgBB052BV7-pdz9HJ99by6JfePN3ery3uiO9ZWYuhGWGeMNBvjpLOKAjVUaCW1lC3rhJO8a74XKdBgFG2ZE0vOdQN0Ca3ic3T-6-2HTbBm3WcfII_r_xP4F_bkYzo |
CitedBy_id | crossref_primary_10_2174_1573396320666230912103056 crossref_primary_10_1073_pnas_1420308112 crossref_primary_10_1002_ppul_26907 crossref_primary_10_4103_ijmr_IJMR_1582_16 crossref_primary_10_1111_mmi_12680 crossref_primary_10_1080_03007995_2018_1505352 crossref_primary_10_1128_mBio_02186_14 crossref_primary_10_1097_INF_0000000000000171 crossref_primary_10_1016_j_rmed_2018_11_016 crossref_primary_10_1371_journal_pone_0102613 crossref_primary_10_1016_j_anai_2017_05_022 crossref_primary_10_1016_j_jaci_2015_09_032 crossref_primary_10_1016_j_anai_2013_01_022 crossref_primary_10_3389_fcimb_2022_882855 crossref_primary_10_1093_infdis_jir557 crossref_primary_10_1378_chest_11_2364 crossref_primary_10_1128_CMR_00114_16 crossref_primary_10_1111_1348_0421_12378 crossref_primary_10_1016_j_iac_2016_03_010 crossref_primary_10_2147_JAA_S313480 crossref_primary_10_3389_fmicb_2021_766591 crossref_primary_10_1111_cmi_13032 crossref_primary_10_1378_chest_11_2909 crossref_primary_10_1371_journal_pone_0062706 crossref_primary_10_1016_j_micpath_2024_106865 crossref_primary_10_1371_journal_pone_0035945 crossref_primary_10_1016_j_jfma_2020_08_018 crossref_primary_10_1128_IAI_00548_17 crossref_primary_10_1093_cid_cir769 crossref_primary_10_1165_rcmb_2011_0135OC crossref_primary_10_1111_j_1365_2222_2011_03944_x crossref_primary_10_1016_j_jaci_2018_07_021 crossref_primary_10_1128_mBio_01497_14 crossref_primary_10_3389_fcimb_2025_1496829 crossref_primary_10_1038_s41598_021_90948_3 crossref_primary_10_1128_mBio_01663_17 crossref_primary_10_1128_spectrum_01588_21 crossref_primary_10_1016_j_ijmm_2018_04_003 crossref_primary_10_1007_s11882_013_0390_8 crossref_primary_10_1165_rcmb_2017_0006OC |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1378/chest.11-0221 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1931-3543 |
ExternalDocumentID | 21622549 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: PHS HHS grantid: U19A1070412-01 – fundername: NIAID NIH HHS grantid: U19 AI070412 |
GroupedDBID | --- .1- .55 .FO .GJ .XZ 08P 0R~ 18M 1P~ 29B 2WC 354 36B 3O- 457 53G 5GY 5RE 5RS 6J9 6PF 7RV 7X7 88E 8AO 8C1 8F7 8FI 8FJ AAEDT AAEDW AAKAS AAKUH AALRI AAWTL AAXUO AAYOK ABDBF ABDQB ABJNI ABLJU ABMAC ABOCM ABUWG ACBMB ACGFO ACGFS ACGUR ACUHS ADBBV ADVLN ADZCM AENEX AEVXI AFCTW AFETI AFFNX AFJKZ AFKRA AFRHN AFTJW AGHFR AHMBA AI. AITUG AJUYK AKRWK ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ AZQEC B0M BCGUY BENPR BKEYQ BKNYI BPHCQ BVXVI C1A C45 CCPQU CGR CS3 CUY CVF DU5 EAP EAS EBC EBD EBS ECM EHN EIF EJD EMK ENC EPT ESX EX3 F5P FDB FYUFA GD~ H13 HMCUK HX~ HZ~ IH2 INR J5H K9- L7B LXL LXN M0R M1P M5~ MJL MV1 N4W N9A NAPCQ NEJ NPM O6. O9- OB3 OBH ODZKP OFXIZ OGROG OHH OI- OU. OVD OVIDX P2P PCD PHGZT PQQKQ PROAC PSQYO Q~Q RIG ROL SJN SSZ TCP TEORI TR2 TUS TWZ UKHRP VH1 W8F WH7 WOQ WOW X7M XOL YFH YHG YOC YQJ Z5R ZGI ZRQ ZXP ZY1 ~8M |
ID | FETCH-LOGICAL-c615t-d0b3efdd7dbdf7fe90a0d03c97c775163f726421629acad9051f3822c4a08a592 |
IngestDate | Thu Apr 03 07:06:20 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c615t-d0b3efdd7dbdf7fe90a0d03c97c775163f726421629acad9051f3822c4a08a592 |
OpenAccessLink | http://journal.chestnet.org/article/S0012369211604145/pdf |
PMID | 21622549 |
ParticipantIDs | pubmed_primary_21622549 |
PublicationCentury | 2000 |
PublicationDate | 2011-08-01 |
PublicationDateYYYYMMDD | 2011-08-01 |
PublicationDate_xml | – month: 08 year: 2011 text: 2011-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Chest |
PublicationTitleAlternate | Chest |
PublicationYear | 2011 |
References | 22315126 - Chest. 2012 Feb;141(2):569-70; author reply 570 |
References_xml | – reference: 22315126 - Chest. 2012 Feb;141(2):569-70; author reply 570 |
SSID | ssj0001196 |
Score | 2.2530491 |
Snippet | The role of Mycoplasma pneumoniae (Mp) in the initiation and persistence of asthma remains elusive. Mp community-acquired respiratory distress syndrome toxin... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 401 |
SubjectTerms | Adhesins, Bacterial - blood Adult Asthma - complications Asthma - microbiology Bacterial Proteins - metabolism Bacterial Toxins - metabolism Community-Acquired Infections Female Humans Male Middle Aged Mycoplasma pneumoniae - metabolism Nasal Lavage Fluid Pneumonia, Mycoplasma - complications Pneumonia, Mycoplasma - microbiology Respiratory Distress Syndrome - complications Respiratory Distress Syndrome - microbiology Sputum - microbiology |
Title | Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21622549 |
Volume | 140 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2ICEuFe8CBfnArXJJYmddH0sBrSqVC63UW-X4oQbUbFRSqbv_gH_dGdvZpFsQj0u0ijfZbObzeGY88w0h73KtrOWCM5EbzWCFtjCllGQq88YWWPzoQ5bvl-nsRByelqeTyc9R1tJVV-2a5S_rSv5HqnAO5IpVsv8g2dVN4QR8BvnCESQMx7-SMaavo5hwcsb0cCz26BZMG0zwdViZMuyk2zoVhvQsBWB3XtcNawPpK4YMjhZm3oI5faF32sZdwf-otYsVL_4yNOZZ7Ogf3XnS5T3BwXm_RRU7dKWua4dDes5XuHkI38z05TfkZ1xlBH8Aw_17rIgI3aOHVl8fa70cbVGMghMx2pqCEy4qVMVzxstIxbTSuJGhKUGrGOlPES--o9e5xFqF0EJsF3-lKG59D8TSXgQhF_m0QJ_3z6NrNNv90AbZAIcDO6hi2Cct6TnoqUTQCk_y_tZzBDrpeO2aaxJMlONHZDP5FnQ_AuUxmbjmCXlwlLInnpLlCC907uldvNARXmiPF9rjha7hhQ54oQNeaN3QAS804uUZOfn86fhgxlLvDWbAxu2YzSruvLXSVtZL71SmM5txo6SRsgQj3ssCa6SnhdJGW2R58xyMTSN0tqdLVTwn95p547YIRaeZK5HtGe0EjCvvtRBlVUprYUFxL8mL-NbO2kiwcta_z1e_HXlNHg5w2yb3Pcxo9wbMw656G0R3A4vgbak |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Persistence+of+community-acquired+respiratory+distress+syndrome+toxin-producing+Mycoplasma+pneumoniae+in+refractory+asthma&rft.jtitle=Chest&rft.au=Peters%2C+Jay&rft.au=Singh%2C+Harjinder&rft.au=Brooks%2C+Edward+G&rft.au=Diaz%2C+Joseph&rft.date=2011-08-01&rft.eissn=1931-3543&rft.volume=140&rft.issue=2&rft.spage=401&rft_id=info:doi/10.1378%2Fchest.11-0221&rft_id=info%3Apmid%2F21622549&rft_id=info%3Apmid%2F21622549&rft.externalDocID=21622549 |